Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 75

Similar articles for PubMed (Select 23728924)

1.

Impact of intravascular ultrasound on the long-term clinical outcomes in the treatment of coronary ostial lesions.

Patel Y, Depta JP, Patel JS, Masrani SK, Novak E, Zajarias A, Kurz HI, Lasala JM, Bach RG, Singh J.

Catheter Cardiovasc Interv. 2013 Jun 1. doi: 10.1002/ccd.25034. [Epub ahead of print]

PMID:
23728924
2.

Long-term outcomes with use of intravascular ultrasound for the treatment of coronary bifurcation lesions.

Patel Y, Depta JP, Novak E, Yeung M, Lavine K, Banerjee S, Lin CH, Zajarias A, Kurz HI, Lasala JM, Bach RG, Singh J.

Am J Cardiol. 2012 Apr 1;109(7):960-5. doi: 10.1016/j.amjcard.2011.11.022. Epub 2012 Jan 31.

PMID:
22296739
3.

Impact of intravascular ultrasound-guided percutaneous coronary intervention on long-term clinical outcomes in a real world population.

Hur SH, Kang SJ, Kim YH, Ahn JM, Park DW, Lee SW, Yun SC, Lee CW, Park SW, Park SJ.

Catheter Cardiovasc Interv. 2013 Feb;81(3):407-16. doi: 10.1002/ccd.23279. Epub 2012 Apr 9.

PMID:
21805605
4.

Sirolimus-eluting stent implantation for ostial left anterior descending coronary artery lesions: three-year outcome from the j-Cypher Registry.

Kishi K, Kimura T, Morimoto T, Namura M, Muramatsu T, Nishikawa H, Hiasa Y, Isshiki T, Nobuyoshi M, Mitsudo K; j-Cypher Registry Investigators.

Circ Cardiovasc Interv. 2011 Aug;4(4):362-70. doi: 10.1161/CIRCINTERVENTIONS.111.961904. Epub 2011 Jun 28.

5.

Impact of intravascular ultrasound guidance in patients with acute myocardial infarction undergoing percutaneous coronary intervention.

Maluenda G, Lemesle G, Ben-Dor I, Collins SD, Syed AI, Torguson R, Kaneshige K, Xue Z, Suddath WO, Satler LF, Kent KM, Lindsay J, Pichard AD, Waksman R.

Catheter Cardiovasc Interv. 2010 Jan 1;75(1):86-92. doi: 10.1002/ccd.22198.

PMID:
19670305
6.

Impact of lesion location on intravascular ultrasound findings and short-term and five-year long-term clinical outcome after percutaneous coronary intervention for saphenous vein graft lesions.

Hong YJ, Jeong MH, Ahn Y, Kang JC, Mintz GS, Kim SW, Lee SY, Kim SY, Pichard AD, Satler LF, Waksman R, Weissman NJ.

Int J Cardiol. 2013 Jul 15;167(1):29-33. doi: 10.1016/j.ijcard.2011.11.078. Epub 2011 Dec 20.

PMID:
22192289
7.

Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.

Freeman M, Clark DJ, Andrianopoulos N, Duffy SJ, Lim HS, Brennan A, Charter K, Shaw J, Horrigan M, Ajani AE, Sebastian M, Reid CM, Farouque HM; Melbourne Interventional Group.

Catheter Cardiovasc Interv. 2009 May 1;73(6):763-8. doi: 10.1002/ccd.21941.

PMID:
19309731
8.

Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry.

Biondi-Zoccai G, Sheiban I, Romagnoli E, De Servi S, Tamburino C, Colombo A, Burzotta F, Presbitero P, Bolognese L, Paloscia L, Rubino P, Sardella G, Briguori C, Niccoli L, Franco G, Di Girolamo D, Piatti L, Greco C, Capodanno D, Sangiorgi G.

Clin Res Cardiol. 2011 Nov;100(11):1021-8. doi: 10.1007/s00392-011-0336-x. Epub 2011 Jun 24.

PMID:
21701872
9.

Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry.

Lee SW, Kim SH, Kim SO, Han S, Kim YH, Park DW, Kang SJ, Lee CW, Park SW, Park SJ.

Catheter Cardiovasc Interv. 2012 Aug 1;80(2):206-12. doi: 10.1002/ccd.23369. Epub 2012 Jan 10.

PMID:
22234884
10.

Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.

Takagi K, Ielasi A, Shannon J, Latib A, Godino C, Davidavicius G, Mussardo M, Ferrarello S, Figini F, Carlino M, Montorfano M, Chieffo A, Nakamura S, Colombo A.

Circ Cardiovasc Interv. 2012 Aug 1;5(4):491-8. doi: 10.1161/CIRCINTERVENTIONS.111.964874. Epub 2012 Jul 31.

11.

The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents.

Roy P, Steinberg DH, Sushinsky SJ, Okabe T, Pinto Slottow TL, Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Weissman NJ, Lindsay J, Waksman R.

Eur Heart J. 2008 Aug;29(15):1851-7. doi: 10.1093/eurheartj/ehn249. Epub 2008 Jun 11.

12.

Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary revascularization in patients with small-vessel disease.

Puymirat E, Peace A, Mangiacapra F, Conte M, Ntarladimas Y, Bartunek J, Vanderheyden M, Wijns W, De Bruyne B, Barbato E.

Circ Cardiovasc Interv. 2012 Feb 1;5(1):62-8. doi: 10.1161/CIRCINTERVENTIONS.111.966937. Epub 2012 Feb 7.

13.

Utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention for type C lesions.

Wakabayashi K, Lindsay J, Laynez-Carnicero A, Ben-Dor I, Sardi G, Torguson R, Xue Z, Satler LF, Pichard AD, Waksman R.

J Interv Cardiol. 2012 Oct;25(5):452-9. doi: 10.1111/j.1540-8183.2012.00744.x. Epub 2012 Jun 7.

PMID:
22672141
14.

Impact of intravascular ultrasound guidance in routine percutaneous coronary intervention for conventional lesions: data from the EXCELLENT trial.

Park KW, Kang SH, Yang HM, Lee HY, Kang HJ, Cho YS, Youn TJ, Koo BK, Chae IH, Kim HS.

Int J Cardiol. 2013 Aug 10;167(3):721-6. doi: 10.1016/j.ijcard.2012.03.059. Epub 2012 Apr 4.

PMID:
22481046
15.

Acute and long-term outcomes of intracoronary stenting in aorto-ostial, left anterior descending artery-ostial and nonostial stenoses.

Huang HL, Hsieh IC, Chang SH, Chang HJ, Chen CC, Hung KC, Wen MS, Wu D.

Int J Cardiol. 2005 Jun 8;101(3):391-7.

PMID:
15907406
16.

Intravascular ultrasound-guided percutaneous coronary intervention improves the clinical outcome in patients undergoing multiple overlapping drug-eluting stents implantation.

Ahn SG, Yoon J, Sung JK, Lee JH, Lee JW, Youn YJ, Ahn MS, Kim JY, Yoo BS, Lee SH, Choe KH.

Korean Circ J. 2013 Apr;43(4):231-8. doi: 10.4070/kcj.2013.43.4.231. Epub 2013 Apr 30.

17.

Two-year outcome of the use of paclitaxel-eluting stents in aorto-ostial lesions.

Tsuchida K, Daemen J, Tanimoto S, García-García HM, Kukreja N, Vaina S, Ong AT, Sianos G, de Jaegere PP, van Domburg RT, Serruys PW.

Int J Cardiol. 2008 Oct 13;129(3):348-53. Epub 2007 Nov 26.

PMID:
18031845
18.

Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.

Luo Y, Yu X, Chen F, Du X, He J, Gao Y, Zhang X, Zhang Y, Ren X, Lv S, Ma C.

Coron Artery Dis. 2012 Aug;23(5):322-9. doi: 10.1097/MCA.0b013e3283564961.

PMID:
22750912
19.

Assessment of the relation between IVUS measurements and clinical outcome in elderly patients after sirolimus-eluting stent implantation for de novo coronary lesions.

Du R, Zhang RY, Zhang Q, Shi YH, Hu J, Yang ZK, Ding FH, Zhang JS, Shen WF.

Int J Cardiovasc Imaging. 2012 Oct;28(7):1653-62. doi: 10.1007/s10554-011-0007-z. Epub 2012 Jan 6.

PMID:
22222382
20.

Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.

Du R, Zhang RY, Zhu ZB, Zhang Q, Hu J, Yang ZK, Yan ZJ, Lv AK, Ding FH, Zhang JS, Shen WF.

Coron Artery Dis. 2010 May;21(3):175-81. doi: 10.1097/MCA.0b013e32833811fe.

PMID:
20305549
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk